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In thoracic aortic disease, diagnostic imaging, prog-
nostic information, surgical outcomes and follow-up
have improved substantially within recent years [1, 2].
As a consequence, cardiovascular anesthesia and sur-
gery are faced with an increasing caseload of thoracic
aortic procedures [3]. 
With decreasing overall and perioperative mortality,
permanent or transient neurological deficits (ND) be-
come the major cause of morbidity, low quality of life
and cost in this group  [4-6].
Etiologies and risks for perioperative ND include 
a) the natural course of disease (e.g., cerebrovascular
involvement [7], embolization, malperfusion [8,9],
dissection, rupture); 
b) emergency and complexity of repair [2,10]
c) use of hypothermic circulatory arrest (HCA)  [2,11-
13].
d) CPB-related damage (e.g., embolization of debris,
gas, fat; malperfusion, dissection, hypoperfusion,
reperfusion injury)
Clinical strategies of all specialties involved in tho-
racic aortic surgery must focus on CNS protection:
A) diagnosis and preparation
a) early diagnosis, close control, elective repair, close
follow-up 
b) surgical indication must balance individual disease
risks against institutional perioperative risks.  
c) elective cases (ascending/arch/thoracoabdominal
aneurysms/chronic dissections) require 
- comprehensive diagnostic workup (angioCT,
MRI; coronaries, carotids; echo, neurological as-
sessment etc.) and 
- interdisciplinary planning with a focus on CNS
protection
d) emergencies (Type A aortic dissection, rupture) re-
quire swift, comprehensive, standardized manage-
ment.
B) surgical strategies
e) usually aim for definitive repair; however, staged or
hybrid procedures may be indicated to reduce is-
chemic risks [14,15]
f) include careful selection of cannulation/crossclamp
sites; axillary/subclavian cannulation is nowadays
preferred over femoral artery cannulation for fear of
retrograde embolization, false lumen perfusion or
dissection [5, 16,17]
g) cannulation injury/embolization can be reduced by
TEE and epiaortic scanning [18-20]
h) periods of hypothermic circulatory arrest (HCA)
without any perfusion support for the brain should
be limited to < 30 min at < 20°C nasopharyngeal
temperature  [21,22].
i) de-airing must be meticulous, using positioning,
CO2-insufflation, flushing, venting or even retro-
grade perfusion.
C) perfusion management
j) must ensure homogeneous cerebral cooling with
temperature gradients of < 10°C, should last for a
sufficient amount of time; EEG silence should al-
ways precede HCA.
k) must minimize periods of cerebral no-flow/low
flow by 
- antegrade cerebral perfusion (ACP) [23,24] and
variants [9, 25-29] using right axillary artery can-
nulation [5] and/or only moderate body hypother-
mia during arrest [30-33]
- HCA may be avoided altogether by appropriately
combining ACP with distal body perfusion [28,34-
36]
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- retrograde CP [6, 10, 37,38] is still used by some
groups despite unproven neuroprotective advan-
tage [39], with the main goals of maintaining
brain hypothermia and removing embolic load
l) optimizing venous drainage [40]
m) rewarming must be controlled to levels strictly be-
low 37°C [41]
D) anesthesia management   
n) Opioid-based regimes are supplemented with
volatile agents or i.v. sedatives. Both for propofol
and current volatiles, neuroprotective and/or neu-
ronal ischemic preconditioning effects have been
demonstrated experimentally. However, evidence
of clinical superiority of any such regime in terms
of neurological outcome is lacking in this patient
population [42,43). Relaxants are empirically indi-
cated to reduce oxygen demand from subclinical
shivering during cooling/rewarming.
o) Neuromonitoring:
- Cerebral perfusion pressure must be reliably mon-
itored by appropriate arterial line placement, ex-
actly adapted to surgical plan and individual
anatomy. This should be combined with continu-
ous proximal internal jugular pressure monitoring
[40]
- Processed EEG helps to monitor for adequate
depth of anesthesia, for episodes of EEG silence
due to hypothermia, hypnotics or ischemia, and
EEG recovery thereafter.
- Multi-site temperature monitoring (nasopharyn-
geal, bilateral tympanic, bladder, CPB inflow etc
[44]) is required to control cooling and rewarming
of brain, core and shell.
- TEE and epiaortic ultrasound have evidence-
based indications in this field [18,45], e.g., assess-
ment of aortic pathology, atheromatosis, valvular
and myocardial function; guidance of cannulation
and de-airing procedures etc.
- Cerebral oximetry by near-infrared spectroscopy
(NIRS) or invasive jugular bulb oximetry is used
to detect critical cerebrovascular Hb desaturation
due to malperfusion, hypotension, hypocapnia, in-
sufficient cooling or ACP flow, brisk rewarming
or other causes of regional or global ischemia. Ev-
idence towards reduction of postoperative ND in
cardiothoracic patients is accruing slowly for non-
invasive continuous NIRS (40,46), but less so for
invasive jugular bulb oximetry [47-49]. 
- Transcranial Doppler has been found useful for
monitoring adequacy of antegrade or retrograde
cerebral perfusion setups [50,51] and for assessing
supraaortic malperfusion or embolic load.
p) Guidance of surgical cannulation 
- During arterial and venous cannulation, TEE,
multisite arterial lines, and CVP readings from the
lumen most proximal to the jugular bulb help to
avoid cannulation disasters (atheroma dislodge-
ment, malposition, dissection, venous obstruction
etc.) 
q) Guidance of brain cooling and rewarming 
- multi-site temperature monitoring assesses homo-
geneity and bilateral synchrony of head tempera-
ture changes.
- Head cooling should be accompanied by appropri-
ate EEG suppression and recovery, as well as by
reversible mydriasis. Mydriasis should rather be
induced by hypothermia than by arrest. 
- Topical head cooling prevents external rewarm-
ing; despite wide empirical use, optimal technique
and neuro-outcome benefits remain unclear [52-
54]
r) Monitoring and guidance of ante- or retrograde
cerebral perfusion 
- flow meter, tympanic T, data from NIRS [46] and
TCD [50,51,55] all give some indication about ad-
equacy of selective cerebral perfusion. 
- The Circle of Willis is incomplete in about 15% of
patients [56]: unilateral (RA-) ACP may not suf-
fice, and may need to be supported by selective L
carotid ACP.
- Run-off of ACP flow (into IMA or L subclavian),
malperfusion or  embolism do occur and may be
detected by appropriate monitoring.
s) Guidance of de-airing 
- By TEE, head-down positioning, intermittent
carotid compression etc. anesthesia contributes to
– largely empirical – efforts to de-air the left heart
and arterial tree (like field flooding with CO2
[57], short RCP, slow reperfusion, agitation, nee-
dle venting etc).
t) “Pharmacologic neuroprotection” [42,43 ]
- A variety of agents is in wide use, but still without
–  even empirical – evidence of benefit [58]
- Steroids: there is no evidence for neuroprotective
efficacy in HCA [59], but hyperglycemic risk is
promoted. 
- Thiopental, Propofol: since decades, clinical evi-
dence for benefit prior to HCA remains insuffi-
cient [21]; bolus doses interfere with EEG moni-
toring and are cerebral vasoconstrictors. Both may
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be useful to normalize cerebral O2 balance at re-
warming [40].
- Volatiles: evidence for clinically useful neuronal
protection and preconditioning is insufficient [42];
agents may reduce CPP but promote cooling and
improve post-CPB myocardial function.
- Aprotinin: despite some neuroprotective evidence
[60], the substance has been withdrawn in 2007.
u) Blood gas management 
- There is wide agreement to use a-stat monitoring
of blood gases
- Inadvertent hypocapnia may impair CBF and
cerebral oxygenation and is to be avoided. 
- Many institutions employ mild hypercapnia dur-
ing cooling for HCA, and α-stat normocapnia dur-
ing rewarming. 
v) Monitoring/guidance of glycemia   
- Hyperglycemia is known to worsen ischemic CNS
damage. Postoperatively, “tight” normoglycemic
control (4.4 – 6.1 mmol/L) has been shown to im-
prove survival after high-risk cardiac surgery [61],
but at a substantial risk of hypoglycemia. Intraop-
eratively, a RCT in cardiac surgery failed to show
any benefits of intraoperative “tight” glycemic
control but undesirable trends in death and stroke
rate [62]. Therefore, intraoperative glycemic con-
trol (e.g., to 4.5 - 9 mmol/L) appears preferable to
“tight” schedules with hypoglycemic risks.
w) Management of coagulation   
- Large transfusion requirement is an independent
predictor of perioperative stroke risk in cardiac
surgery [63]. Tranexamic acid has been shown to
reduce transfusion requirement in thoracic aortic
surgery [64]. Reduction of homologous transfu-
sion (and in particular, platelets) by appropriate
point-of-care testing and transfusion algorithms
may open new approaches to reduce ND in tho-
racic aortic surgery.  
x) Temperature management 
- Postischemic hyperthermia worsens neurologic
outcome [41]. After thoracic aortic surgery, T >
37° in perfusate, core, nasopharynx or tympanon
of patients must be avoided at all times, by early
start of rewarming, by keeping patient-perfusate
gradients < 10 °C, by stopping rewarming at na-
sopharyngeal T ≤ 36.5°Core (even at the cost of
some afterdrop), and slow correction by external
warming devices [65].
Summary
In thoracic aortic surgery and anesthesia, caseload and
complexity is increasing. The variety of mechanisms
contributing to adverse neurological outcomes is large
and difficult to control in this type of surgery. Never-
theless, in most published series, rates of major neu-
rodeficits are clearly decreasing over time. 
Major progress in neuroprotection has been made by
modifying surgical and perfusion strategies, but most-
ly experimentally and empirically with relatively few
human RCT. Cardiac anesthesiology has contributed
substantially by echocardiographic and neuromonitor-
ing input, and improved management of cerebral he-
modynamics, coagulation, metabolism and tempera-
ture. Disappointingly, after decades of well-conducted
preclinical research, pharmacologic neuroprotectants
have yet to produce clinical evidence of efficacy and
safety. 
Further progress is expected to come both from new
hybrid technology, from increasing institutional case-
load and intensified team experience. At the moment,
the observational character of most studies in the field
makes development of evidence-based recommenda-
tions difficult.
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